IsoPlexis Corporation, based in Branford, CT, is a leading functional cell biology company formed through the combination of Berkeley Lights and IsoPlexis. Their premier platforms, Beacon and IsoSpark, offer a wide range of applications in immune medicine, providing solutions for single-cell secretome, signaling, metabolome, and multiomics analysis. With their award-winning proteomics hub and advanced informatics suite, IsoPlexis is at the forefront of research and innovation in the field of functional cell biology.
With a focus on unique biology and true single T cell biology, IsoPlexis offers insights into cancer immunology, infectious disease vaccines, cellular regenerative medicine, inflammation neurology, and oncology. Their comprehensive product suite, supported by partnerships with industry leaders, enables labs to accelerate their research and gain valuable data easily and rapidly. IsoPlexis is dedicated to empowering labs and changing human health through their cutting-edge proteomic products and solutions.
Generated from the website